700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02600

Synthetic patientMETA-24 · Day 180 · 25–34 · M · baseline S01Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
4%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability-8
  • Treatment adherence-5
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    86 min
    stable · -1.4 vs previous 14 d
    Sleep duration
    Wearable
    6.8 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    7.6/10
    stable · -0.0 vs previous 14 d
    Steps
    Wearable
    8,721
    stable · -219 vs previous 14 d
    GI burden
    Companion
    2.8/100
    worsening · +5.8 vs previous 14 d
    Adherence
    Companion
    87.9 %
    stable · -0.4 vs previous 14 d
    Sleep quality
    Wearable
    48.8/100
    worsening · -3.9 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    131 mg/dL
    stable · +3.8 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 105 from the failing basin, 19 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.8
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -5.8 next day
    Main detractors to watch
    • Ultra-processed food
      perturbation · steering -7.8
    • IL6 high-expression variant
      hidden · steering -7.3
    • Alcohol
      perturbation · steering -6.1
    • Antibiotic course
      perturbation · steering -4.7
    • Ultra-processed food
      detractor · GI +5.3 next day
    • Alcohol
      detractor · GI +3.9 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.8supporter · 95%
    • Ultra-processed food
      +5.3detractor · 95%
    • Alcohol
      +3.9detractor · 70%
    • Caffeine
      +2no signal · 38%
    • Insoluble fibre
      +1.6no signal · 38%
    • Dietary fat load
      +1.2no signal · 29%
    • Simple carbohydrates
      -1no signal · 22%
    • Histamine load
      +0.4no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↓25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery ↓25
      • WearableResting HR 72 bpm
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.1 · butyrate capacity 47/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    55 ms
    Sleep
    6.4 h
    Steps
    9,020
    Resting HR
    73 bpm
    Daily log: GI score 3, nutritional resilience 71, adherence 88.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0227746%S05AD-05improved92
    P-0248646%S10ME-01improved86
    P-0206842%S14NP-02improved83
    P-0212741%S11SC-12improved73
    P-0245041%S12NP-02improved92
    P-0224939%S09DT-01improved100
    P-0263039%S17NP-02improved76
    P-0241538%S17GI-04improved86
    P-0246438%S18ME-01improved68
    P-0266737%S08HY-01improved77
    P-0269037%S02ME-01improved73
    P-0244135%S11SC-12improved67